To determine the association of G9A overexpression in breast cancer patients with clinical outcome, G9A expression levels and the corresponding survival data were examined using the Kaplan-Meier Plotter [27] database of microarray gene expression. The gene discussed is EHMT2; the disease is breast carcinoma.